Published in Thorax on September 01, 1983
A self management plan in the treatment of adult asthma. Thorax (1989) 5.85
Do large volume spacer devices reduce the systemic effects of high dose inhaled corticosteroids? Thorax (1990) 2.43
Adrenal function in asthma. Arch Dis Child (1990) 2.29
Adverse effects of inhaled corticosteroids. BMJ (1989) 1.91
Comparison of two high dose corticosteroid aerosol treatments, beclomethasone dipropionate (1500 micrograms/day) and budesonide (1600 micrograms/day), for chronic asthma. Thorax (1986) 1.81
Effect of a volumatic spacer and mouth rinsing on systemic absorption of inhaled corticosteroids from a metered dose inhaler and dry powder inhaler. Thorax (1991) 1.79
Morning serum cortisol concentrations after 2 mg inhaled beclomethasone dipropionate in normal subjects: effect of a 750 ml spacing device. Thorax (1990) 1.64
Bone turnover during high dose inhaled corticosteroid treatment. Thorax (1991) 1.59
Purpura and dermal thinning associated with high dose inhaled corticosteroids. BMJ (1990) 1.54
Effect of high dose inhaled beclomethasone dipropionate on carbohydrate and lipid metabolism in normal subjects. Thorax (1987) 1.48
Therapeutic aerosols 2--Drugs available by the inhaled route. Thorax (1984) 1.23
Effects of high doses of inhaled corticosteroids on adrenal function in children with severe persistent asthma. Thorax (1993) 1.05
Systemic effects of inhaled corticosteroids: an overview. Open Respir Med J (2014) 0.97
Large volume spacer devices and the influence of high dose beclomethasone dipropionate on hypothalamo-pituitary-adrenal axis function. Thorax (1993) 0.85
Pharmacokinetics of epimeric budesonide and fluticasone propionate after repeat dose inhalation--intersubject variability in systemic absorption from the lung. Br J Clin Pharmacol (2000) 0.83
Long-term management of reversible obstructive airways disease in adults. Lung (1990) 0.75
Aerosol beclomethasone dipropionate: a dose-response study in chronic bronchial asthma. Lancet (1973) 4.12
High-dose beclomethasone inhaler in the treatment of asthma. Lancet (1983) 2.58
The effect of oral and inhaled beclomethasone dipropionate on adrenal function. Clin Allergy (1973) 1.96
Response of patients receiving high dose beclomethasone dipropionate. Thorax (1974) 1.72
Drug spotlight program: systemic corticosteroid therapy: pharmacology and endocrinologic considerations. Ann Intern Med (1974) 1.54
A graded dose assessment of the efficacy of beclomethasone dipropionate aerosol for severe chronic asthma. J Allergy Clin Immunol (1977) 1.43
Reliability of the 30-minute ACTH test in assessing hypothalamic-pituitary-adrenal function. J Clin Endocrinol Metab (1978) 1.27
Properties and therapeutic uses of some corticosteroids with enhanced topical potency. J Steroid Biochem (1975) 0.99
Inhaled steroid aerosols and alternate-day prednisone. Lancet (1979) 0.93
A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature (1990) 10.97
Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature (1980) 9.25
Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann Neurol (1999) 7.69
Nucleotide sequence of Abelson murine leukemia virus genome: structural similarity of its transforming gene product to other onc gene products with tyrosine-specific kinase activity. Proc Natl Acad Sci U S A (1983) 4.32
Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans. Nature (1996) 4.12
Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nat Med (1995) 3.61
The Memorial Delirium Assessment Scale. J Pain Symptom Manage (1997) 3.55
Identification of the cystic fibrosis gene. BMJ (1990) 3.28
Independent genetic determinants of pancreatic and pulmonary status in cystic fibrosis. Lancet (1990) 3.27
Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. Eur Respir J (2000) 3.14
Q fever endocarditis treated with trimethoprim and sulphamethoxazole. Br Med J (1972) 3.06
Nucleotide sequence analysis of the transforming region and large terminal redundancies of Moloney murine sarcoma virus. Proc Natl Acad Sci U S A (1980) 2.93
Aerosol carbenicillin and gentamicin treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis. Lancet (1981) 2.87
Liver disease and bile duct abnormalities in adults with cystic fibrosis. Lancet (1989) 2.76
The relationship of phenotype changes in Pseudomonas aeruginosa to the clinical condition of patients with cystic fibrosis. Am Rev Respir Dis (1983) 2.68
An association between actin and the major histocompatibility antigen H-2. Nature (1978) 2.63
High-dose beclomethasone inhaler in the treatment of asthma. Lancet (1983) 2.58
Complete nucleotide sequence and organization of the Moloney murine sarcoma virus genome. Science (1981) 2.51
Studies on nucleic acid reassociation kinetics: reactivity of single-stranded tails in DNA-DNA renaturation. Proc Natl Acad Sci U S A (1975) 2.50
Wasting as an independent predictor of mortality in patients with cystic fibrosis. Thorax (2001) 2.50
Cystic fibrosis in adolescents and adults. Thorax (1987) 2.47
Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly. FEBS Lett (1998) 2.26
A safety screening questionnaire for transcranial magnetic stimulation. Clin Neurophysiol (2001) 2.20
Evaluation of the forced expiration technique as an adjunct to postural drainage in treatment of cystic fibrosis. Br Med J (1979) 2.15
Leukotriene B: a potential mediator of inflammation. J Pharm Pharmacol (1980) 2.13
A prognostic model for the prediction of survival in cystic fibrosis. Thorax (1997) 2.10
Meconium ileus equivalent in adults with cystic fibrosis of pancreas: a report of six cases. Br Med J (1976) 2.02
Management of pneumothorax in adults with cystic fibrosis. Thorax (1982) 1.99
Alterations in the SMARCB1 (INI1) tumor suppressor gene in familial schwannomatosis. Clin Genet (2008) 1.84
The Yersinia enterocolitica motility master regulatory operon, flhDC, is required for flagellin production, swimming motility, and swarming motility. J Bacteriol (1999) 1.81
Association of HLA B8 with spontaneous resolution in sarcoidosis. Thorax (1981) 1.80
Coeliac disease and diffuse interstitial lung disease. Lancet (1971) 1.80
Autoantibodies against bactericidal/permeability-increasing protein in patients with cystic fibrosis. QJM (1996) 1.78
Malignant mesothelioma of the pleura: relation between histological type and clinical behaviour. Thorax (1982) 1.76
Long term venous access using a totally implantable drug delivery system in patients with cystic fibrosis and bronchiectasis. Respir Med (1989) 1.75
Improved survival at low lung function in cystic fibrosis: cohort study from 1990 to 2007. BMJ (2011) 1.74
Structure of tau exon 10 splicing regulatory element RNA and destabilization by mutations of frontotemporal dementia and parkinsonism linked to chromosome 17. Proc Natl Acad Sci U S A (1999) 1.73
Medium term treatment of stable stage cystic fibrosis with recombinant human DNase I. Thorax (1995) 1.72
Models for tertiary structures. Myoglobin and lysozyme. J Chem Educ (1970) 1.70
Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial. Lancet (1999) 1.69
Oral ciprofloxacin compared with conventional intravenous treatment for Pseudomonas aeruginosa infection in adults with cystic fibrosis. Lancet (1987) 1.66
Length heteroplasmy of sturgeon mitochondrial DNA: an illegitimate elongation model. Genetics (1990) 1.65
Demographic and social characteristics of adults with cystic fibrosis in the United Kingdom. BMJ (1993) 1.65
Quality of life in adults with cystic fibrosis. Thorax (1996) 1.64
Mycobacterial isolations in young adults with cystic fibrosis. Thorax (1984) 1.60
Leukotriene B4: a mediator of vascular permeability. Br J Pharmacol (1981) 1.57
Methicillin-resistant Staphylococcus aureus: impact at a national cystic fibrosis centre. J Hosp Infect (1998) 1.55
Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study. Epidemiologic Registry of Cystic Fibrosis. Eur Respir J (2000) 1.54
Altered insulin secretory responses to glucose in subjects with a mutation in the MODY1 gene on chromosome 20. Diabetes (1995) 1.54
Work organization and ergonomics. Appl Ergon (2000) 1.53
Hospital care for adults with cystic fibrosis: an overview and comparison between special cystic fibrosis clinics and general clinics using a patient questionnaire. Thorax (1994) 1.52
Interaction of corticosteroids and catecholamines in the treatment of asthma. Thorax (1975) 1.52
Influence of moderate daily wine consumption on body weight regulation and metabolism in healthy free-living males. J Am Coll Nutr (1997) 1.51
Pelvic lipomatosis: 35-year experience. J Urol (1988) 1.50
Surgical delay in the management of dog bite injuries in children, does it increase the risk of infection? J Plast Reconstr Aesthet Surg (2006) 1.50
Presence of cystic fibrosis-related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: data from the European Epidemiologic Registry of Cystic Fibrosis. Pediatr Pulmonol (2001) 1.49
Characterisation of the normal right ventricular pressure-volume relation by biplane angiography and simultaneous micromanometer pressure measurements. Br Heart J (1988) 1.48
Hospitalised patients' views on doctors and white coats. Med J Aust (2001) 1.48
Leukotriene B4: an inflammatory mediator in vivo. Prostaglandins (1981) 1.48
Anti-inflammatory drugs, prostaglandins and leucocyte migration. Agents Actions (1976) 1.45
A method for extracting ferruginous bodies from sputum and pulmonary tissue. Am J Clin Pathol (1972) 1.44
Physicochemical evolution and molecular adaptation of the cetacean and artiodactyl cytochrome b proteins. Mol Biol Evol (2004) 1.44
Circulating immune complexes in patients with cryptogenic fibrosing alveolitis. Clin Exp Immunol (1979) 1.44
The effects of salicylate on the activity of rat liver tryptophan pyrrolase in vitro and in vivo. Biochem J (1971) 1.43
Obesity-induced hypertension. Renal function and systemic hemodynamics. Hypertension (1993) 1.43
Physical trauma and breast cancer. Lancet (1994) 1.42
Sweat tests to diagnose cystic fibrosis in adults. Br Med J (Clin Res Ed) (1983) 1.41
Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation. J Clin Invest (1995) 1.40
Changes in liver tryptophan and tryptophan pyrrolase activity after administration of salicylate and tryptophan to the rat. Biochem Pharmacol (1972) 1.40
Twice vs three-times daily antibiotics in the treatment of pulmonary exacerbations of cystic fibrosis. J Cyst Fibros (2011) 1.40
Three incidents of industrial mass psychogenic illness: a preliminary report. J Occup Med (1978) 1.40
Intermediate-term results of heart-lung transplantation for cystic fibrosis. Lancet (1992) 1.40
The myth of the Brooks method of embolization: a brief history of the endovascular treatment of carotid-cavernous sinus fistula. J Neurointerv Surg (2009) 1.39
Inhalation of antibiotics in cystic fibrosis. Eur Respir J (1995) 1.39
Dealing with skewed data: an example using asthma-related costs of medicaid clients. Clin Ther (2001) 1.38
Adult cystic fibrosis: association of acute pulmonary exacerbations and increasing severity of lung disease with auxotrophic mutants of Pseudomonas aeruginosa. Thorax (1993) 1.37
Increased sputum amino acid concentrations and auxotrophy of Pseudomonas aeruginosa in severe cystic fibrosis lung disease. Thorax (2000) 1.37
Importance of viruses and Legionella pneumophila in respiratory exacerbations of young adults with cystic fibrosis. Thorax (1984) 1.36
Leukotriene B4, a mediator of inflammation present in synovial fluid in rheumatoid arthritis. Ann Rheum Dis (1983) 1.35
Linked marker haplotypes and the delta F508 mutation in adults with mild pulmonary disease and cystic fibrosis. Lancet (1990) 1.35
Exstrophy closure: a followup on 70 cases. J Urol (1966) 1.34
Lack of inducible nitric oxide synthase in bronchial epithelium: a possible mechanism of susceptibility to infection in cystic fibrosis. J Pathol (1998) 1.34
Radiology of uncomplicated asthma. Thorax (1974) 1.33
Flavone acetic acid (NSC 347512) induces haemorrhagic necrosis of mouse colon 26 and 38 tumours. Eur J Cancer Clin Oncol (1987) 1.33
Isomers of leukotriene B4 possess different biological potencies. Prostaglandins (1981) 1.33
The effects of some antirheumatic drugs on an in vitro model of human polymorphonuclear leucocyte chemokinesis. Br J Pharmacol (1980) 1.33
Cystic fibrosis. Postgrad Med J (1984) 1.32
Nasal potential difference: a clinical diagnostic test for cystic fibrosis. Eur Respir J (1990) 1.32
A cohort study of cystic fibrosis and malignancy. Br J Cancer (1993) 1.31
Vertebral deformities and low bone mineral density in adults with cystic fibrosis: a cross-sectional study. Osteoporos Int (2001) 1.27
High-titre anti-CMV plasma in treatment of neonatal cytomegalovirus infection. Lancet (1984) 1.24
Clinical review of pulmonary disease caused by Mycobacterium xenopi. Thorax (1983) 1.23
Sequence of tRNA(Thr) and tRNA(Pro) from white sturgeon (Acipenser transmontanus) mitochondria. Nucleic Acids Res (1988) 1.23
Effects of a human plasma fraction on leucocyte migration into inflammatory exudates. J Pharm Pharmacol (1975) 1.23
The relationship between reasons for drinking alcohol and alcohol consumption: an interactional approach. Addict Behav (1994) 1.23
Spectral analysis of Doppler signals and computation of the normalised first moment in real time using a digital signal processor. Med Biol Eng Comput (1988) 1.22